CANNABIS SATIVA, INC - OTCQB: CBDS
Cannabis Sativa, Inc. Awarded Patent for "Ecuadorian Sativa" Cannabis Plan
MESQUITE, NV / ACCESSWIRE / December 21, 2016 / Cannabis Sativa, Inc. (CBDS) announced that on December 20, 2016, the company's subsidiary was awarded Patent PP27,475 for a Cannabis Plant named "Ecuadorian Sativa".
"Equadorian Sativa" has been shown in laboratory testing by Steephill Labs to have a Limonene level that is extraordinarily high at a level of 4.53, 10 to 20 times the usual range. This sets "Equadorian Sativa" apart from other varieties in its odor, the effects on mood and mentation and its medical qualities.
The objective of the breeding, which produced this novel plant strain nicknamed "CTA", was primarily to develop a plant having the following characteristics: (a) medicinal properties that included hypotensive activity; (b) psychoactive properties that motivated and energized, rather than creating lethargy, sleepiness, and (c) increased food consumption.
Anecdotally, there are indications that its use may prevent some cancers and may cause apoptosis of cancer cells in vivo. There is a good possibility that the high levels of limonene may slow down the build-up of plaque in the arteries and reduce the effect of low-density lipo-proteins on the circulatory system. Indications are that "Ecuadorian Sativa" has many medical qualities that make it an important tool to maintain health and deal with illness.
"Our patience is now rewarded with the issuance of Patent PP27,475". "This patent will open up new areas for research and opportunities for CBDS", said CEO Mike Gravel.
This plant was derived from a female said to be of a strain called colloquially, "Celestial Temple Sativa" an individual grown in Ecuador that as a solitary plant reached a height of 23 feet. The male parent is said to have been of a strain known colloquially as "Island Sweet Skunk".
The Company's President David Tobias said, "This is a major accomplishment and is a tribute to the foresight and perseverance of management to solidify Cannabis Sativa's contribution to the maturing Cannabis industry."
"It is our ambition to brand and market the highest quality, legal cannabis products available today – and to innovate the industry-leading products of tomorrow.
We forsee a future where the hi brand is synonymous with the highest quality and best value in the cannabis space; a vision we plan to support through aggressive marketing and strategic alliances".
Cannabis Sativa, Inc. (OTCQB:CBDS) has global ambitions. We believe cannabis is destined to become the next gold rush, and we're prepared to help shape its future in a legal environment. -- CLICK HERE TO READ CANNABIS SATIVA, INC PRESS RELEASES --
We've assembled the team, the talent and the experience necessary to brand and market the highest-quality cannabis products available today – and to innovate the future of casual cannabis.
Cannabis Sativa, Inc. Enters Agreement to Acquire Real Estate for Organic Hemp Farm in California
MESQUITE, NV / ACCESSWIRE / December 19, 2016 / Cannabis Sativa, Inc. (OTCQB:CBDS) announced today that it entered into an agreement to acquire a 49% ownership interest in a 9 acre property in Los Angeles County, California. The ownership group plans to lease the property to an industrial hemp farm operator who will conduct farming activities under the Industrial Hemp provisions of California's Adult Use Marijuana Act (Prop 64). The Company's President David Tobias stated, "We are excited to play a role in what we anticipate will be one of California's first hemp farms under Prop 64." The farm will produce organic industrial hemp derived products. It is anticipated that the farm will fill part of the Company's demand for industrial hemp based products, with California grown organic industrial hemp. Farming activities are expected to commence in January of 2017.
Cannabis Sativa Adds IP to Portfolio
MESQUITE, NV / ACCESSWIRE / December 14, 2016 / Cannabis Sativa (OTCQB:CBDS) announces that it has acquired several Federally Registered marks to augment its intellectual property portfolio including Cannabis*SativaÂ®, DISPENSARxYÂ®, and CannaRxÂ®. "We believe that having a strong IP portfolio is essential to our on-going branding emphasis," said CBDS President David Tobias. "A recent article in High Times Magazine stated that "the next quantum leap in the cannabis industry won't be in banking or tax codes, it'll be in branding and intellectual property," and we continue staking our claim." "The marks are currently in the process of "assignment of ownership" from the seller, and depending on the workload of the USPTO, assignment can take several weeks to complete," Tobias stated.
The IP identifiers are Cannabis*SativaÂ®, Registration Number 4,868,623, DISPENSARxYÂ®, Registration Number 4,642,830 and CannaRxÂ®, Registration Number 4,725,687. The Marks are registered in CL 35 under Goods and Services:
Goods and Services
IC 035. US 100 101 102. G & S: Business consultation services in the field of telling others how to bring together a variety of industrial hemp based products so as to enable their consumers to be aware of the health benefits of such goods and to view and purchase such goods. FIRST USE: 20140416. FIRST USE IN COMMERCE: 20140416